Arch Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 31 Aug 23 | BuyUS$2,830 | Drake Partners Equity Llc | Company | 10,292 | US$0.28 | |
| 31 Aug 23 | BuyUS$2,830 | Michael Abrams | Individual | 10,292 | US$0.28 | |
| 31 Aug 23 | BuyUS$1,887 | Terrence Norchi | Individual | 6,862 | US$0.28 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 10,973 | 0.247% |
| Hedge Funds | 300,000 | 6.75% |
| Institutions | 600,000 | 13.5% |
| VC/PE Firms | 600,000 | 13.5% |
| Individual Insiders | 900,138 | 20.3% |
| General Public | 2,033,252 | 45.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 248.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 300,000 | US$354.0k | 0% | no data | |||
| 300,000 | US$354.0k | 0% | 37.29% | |||
| 300,000 | US$354.0k | 0% | 100.0% | |||
| 300,000 | US$354.0k | 0% | no data | |||
| 300,000 | US$354.0k | 0% | no data | |||
| 300,000 | US$354.0k | 0% | no data | |||
| 205,124 | US$242.0k | -12.9% | no data | |||
| 150,000 | US$177.0k | 0% | 1.88% | |||
| 150,000 | US$177.0k | 0% | 1.7% | |||
| 75,023 | US$88.5k | 0% | no data | |||
| 10,973 | US$12.9k | 0% | no data | |||
| 10,836 | US$12.8k | 0% | no data | |||
| 8,405 | US$9.9k | -87% | no data | |||
| 750 | US$885.2 | 0% | no data |